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Introduction
Fibrinogen gamma prime (γ'; previously also called γB or γ57.5) arises from a splice variant of the γ chain mRNA resulting from an alternative polyadenylation signal in intron 9.
1,2 The alternative polyadenylation leads to the translation of a unique 20-amino acid C-terminal extension encoded by intron 9, which substitutes the 4 γA amino acids of exon 10. [2] [3] [4] Approximately 8-15% of total fibrinogen is comprised of γ'
and 12.1% (±8.11) respectively. Table 1 presents the correlation between γ' fibrinogen, γ'/total fibrinogen ratio and total fibrinogen and markers of clot formation and structure in plasma. Lag time did not show noteworthy correlations with any of the fibrinogen variables. Slope showed the strongest correlation with total fibrinogen (r=0.37). Maximum absorbance showed a positive correlation with total fibrinogen (r=0.58) and γ' fibrinogen (r=0.36), and a negative correlation with γ'/total fibrinogen ratio (r=-0.21). The correlation between γ' fibrinogen and maximum absorbance, although less strong remained significant after adjustment for total fibrinogen (r= 0.17, p<0.0001 -data not shown). Clot lysis time showed the strongest correlation with γ' fibrinogen (r=0.36). Fibrinogen γ' correlated positively with both γ'/total fibrinogen ratio (r=0.53) and total fibrinogen (r=0.40) while γ'/total fibrinogen ratio correlated negatively with total fibrinogen (r= -0.56).
The contribution of fibrinogen variables to the variance in the markers of clot formation and structure was analysed using univariate regression models ( Table 2 ).
The results of the regression models are in agreement with the correlations observed. None of the fibrinogen variables contributed significantly to the variance in lag time (all 1% or less). Total fibrinogen was the largest contributor to variance in slope explaining 14% of the variance. Total fibrinogen was also the largest contributor to the variance in maximum absorbance, explaining 33% of the variance, with γ' fibrinogen explaining 13.5%. The γ'/total fibrinogen ratio additionally explained 4.5% of the variance in maximum absorbance, with an increase in the ratio being associated with a decreased maximum absorbance. Fibrinogen γ' was the largest contributor to clot lysis time, explaining 12% of its variance.
The association of γ' fibrinogen, γ'/total fibrinogen ratio and total fibrinogen with CVD risk markers was analysed by stratification of the CVD risk markers and comparison of the distribution of the fibrinogen variables between the strata (Table 3 and Online Supplement 2). If total fibrinogen differed between the strata an ANCOVA was performed for γ' fibrinogen and γ'/total fibrinogen ratio adjusting for total fibrinogen.
All three fibrinogen variables increased significantly with abdominal obesity and increasing BMI and CRP categories and the significance for γ' fibrinogen and γ'/total fibrinogen ratio remained after adjustment for total fibrinogen (Table 3) . Individuals
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From with low HDL-cholesterol had higher levels of all fibrinogen variables and the significance for γ' fibrinogen and γ'/total fibrinogen ratio also remained after adjustment for total fibrinogen. Participants with the metabolic syndrome (using the criteria recommended by Alberti et al 26 ) also had higher levels of all fibrinogen variables than those without metabolic syndrome and the significance for γ' fibrinogen and γ'/total fibrinogen ratio remained after adjustment for total fibrinogen.
The same pattern was observed for increasing HbA1c categories (Online Supplement 2). Women had higher γ' fibrinogen, γ'/total fibrinogen ratio and total fibrinogen than men. Total fibrinogen increased with 10-year age categories, while γ' fibrinogen did not. Individuals with increased total cholesterol had increased total fibrinogen but not γ' fibrinogen. Individuals with hyperhomocysteinaemia had lower γ'
fibrinogen and γ'/total fibrinogen ratio but similar total fibrinogen compared to individuals with normal homocystein levels. Total fibrinogen was moderately increased in individuals with hypertension while no difference was observed for γ'
fibrinogen.
To determine the respective contribution of the CVD risk factors to the variance in γ'
fibrinogen and the γ'/total fibrinogen ratio, the CVD risk factors presented in Table   3 /Online Supplement with and without total fibrinogen and or γ' fibrinogen were entered into forward stepwise regression models (Table 4 ). The CVD risk factors together with fibrinogen explained 26.3 % of the variance in γ' fibrinogen, with total fibrinogen explaining 16%, followed by CRP (5%), HDL-cholesterol (3%), gender (2%), HbA1c (1%) and homocysteine (1%). When fibrinogen was excluded from the model, the CVD risk factors alone explained 19.9% of the variance in γ' fibrinogen, with CRP now explaining 13.5 % and little change in the contribution of the other CVD risk factors. When total fibrinogen or γ' fibrinogen was entered together with the CVD risk factors, the models explained 39.3%, and 37%, respectively of the variance in γ'/total fibrinogen ratio. The CVD risk factors alone explained only 3% of the variance of which CRP and HDL-cholesterol made the largest contribution.
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Discussion
Our data provide evidence that γ' fibrinogen influences fibrin clot structure in plasma.
It has been shown that γ' fibrinogen changes fibrin structure in vitro in purified systems at levels of 100%, [12] [13] [14] [15] [16] however, whether such effects would also occur at physiological levels of 10-15% γ' fibrinogen and in the presence of other plasma proteins was hitherto unknown. We used a large, well-characterised population based study to show that this is indeed the case. We found associations of γ'/total fibrinogen ratio with lower maximum absorbency and prolongation of lysis time, in agreement with previously published in vitro effects. We also found that γ' fibrinogen levels associate with other cardiovascular risk factors and not only total fibrinogen levels.
Fibrinogen γ' levels correlated positively with total fibrinogen, although the γ'/total fibrinogen ratio decreased with increasing fibrinogen concentration, suggesting that while γ' fibrinogen increases as total fibrinogen increases, it does so to a relatively lesser extent (i.e. γ' levels were not a constant fraction of total fibrinogen levels throughout the entire range of fibrinogen concentrations), resulting in the decreased ratio at higher total fibrinogen levels. The median γ' fibrinogen concentration in this black African population is higher to what was previously reported for Caucasians from the Framingham Offspring study (0.38 vs 0.23g/L). This is in agreement with the relatively high total fibrinogen concentration (3.7 g/L) found in this and other studies investigating fibrinogen concentration in black Africans.
23;27
Turbidity curves are often used as a measure of clot formation and structure in large datasets due to its high throughput methodology. 28 Its relevance is further supported by the fact that final clot structure is to a large extent kinetically controlled and therefore information on clot formation is critical in determining clot structure.
29;30
None of the fibrinogen variables, showed noteworthy associations with lag time.
This is likely due to the fact that the samples were clotted with tissue factor which resulted in lag time not only representing the time required for the formation and growth of protofibrils from monomers, but also the time required for activation of the coagulation cascade. Tissue factor rather than thrombin was used to clot the samples as it allows for comprehensive analysis of plasma fibrinolytic potential concentration. An increase in γ' fibrinogen was associated with a small increase in rate of lateral aggregation, while an increase in the γ'/total fibrinogen ratio was associated with a small decrease. When adjusting for difference in total fibrinogen, the association between γ' fibrinogen and slope disappeared, suggesting that in vivo (at least in the plasma setting) γ' fibrinogen does not significantly affect rate of lateral aggregation despite decreased rates observed in purified models for clots made of γ' compared to γA fibrinogen. 12;15;16 It may be that the effects of γ' fibrinogen in plasma is relatively small compared to the effect of increasing fibrinogen concentration in this setting.
The variance in maximum absorbance was explained to a much larger extent (>30%)
by the fibrinogen variables than either lag time or slope. An increase in both γ' fibrinogen and total fibrinogen was associated with an increased maximum absorbance with total fibrinogen contributing to a larger extent than γ' fibrinogen. An increase in the γ'/total fibrinogen ratio was, however associated with a decrease in maximum absorbance. In agreement with this, turbidity curves obtained from purified fibrinogen models showed decreased maximum absorbance in clots containing γ' compared to γA fibrinogen, indicating that the γ'/total fibrinogen ratio is indeed an accurate indicator for the relative amount of γ' in the plasma clot. 12;15;16 Reduced maximum absorbance from turbidity analysis is an indicator of thinner fibrin fibres at constant fibrinogen concentration. The effect of γ' fibrinogen on fibre 1 1 diameter as measured by scanning electron microscopy in vitro is generally in agreement with this. Several studies showed that clots containing γ' fibrinogen have thinner fibres. 12;14-16 Others, however, using a recombinant homodimer form of fibrinogen γ', found no difference in fibre diameter. 13 Several studies showed that fibrinogen γ' fibrinogen produced clots with increased branching. 14;16 Additionally it was found that clots containing γ' fibrinogen were non-homogenously arranged into tight interconnecting bundles with tighter pores with bundled fibres and large open pores in other areas of the clot. 15;16 While the use of plasma samples is of immense value in determining the in vivo relationship between γ' fibrinogen, total fibrinogen and clot structure, the interpretation of experimental results, especially from an indirect technique such as turbidity, is complicated due to the complex nature of plasma, and the interplay of factors that determine maximum absorbency including fibrinogen concentration and average fibrin fibre diameter. Because of the high throughput design of turbidity analysis, and the time consuming nature of more direct methods (such as microscopy), it can, however play a significant role in providing information regarding clot structure in an epidemiological study setting with large subject numbers.
There has been only one previous study that investigated the effect of γ' fibrinogen concentration on clot structure in plasma. Mannila et al 8 investigated the effect of γ' fibrinogen concentration on plasma permeability (Ks) and fibre mass-length ratio (µ calculated from Ks) in 60 control patients from the Stockholm Coronary Artery Risk Factor (SCARF) study. Fibrinogen γ' concentration was not found to be associated with Ks or µ. However, the authors did not analyse γ'/total fibrinogen ratio and the overall study size was probably too small to detect the relatively moderate effects of physiological levels of γ' fibrinogen on clot structure. Our current study is much larger in size and showed significant effects of γ' fibrinogen on plasma clot structure.
In particular, the γ'/total fibrinogen ratio showed similar effects on clot structure as previous in vitro studies, with an association of increased γ' fibrinogen content with thinner fibres (lower maximum absorbance) and prolonged fibrinolysis.
Although CLT correlated positively with both γ' fibrinogen and total fibrinogen, fibrinogen γ' had the strongest association with CLT, explaining 12% of its variance.
This suggests γ' fibrinogen to have a larger effect on CLT than total fibrinogen. An increased CLT indicates decreased lysis rate, which is in agreement with results from studies using purified fibrinogen which showed decreased lysis rates for clots containing γ' compared to γA fibrinogen. 13;14;31 Falls and Farrell 31 additionally found decreased lysis rates in afibrinogenaemic plasma to which γA/γ' fibrinogen was added compared to plasma containing an equal concentration of γA/γA fibrinogen.
They ascribed the decreased fibrinolysis rate to increased FXIII binding to γ'
fibrinogen and subsequent increased crosslinking. Allan et al 16 , however, found no difference in γ-chain crosslinking between γA/γA and γA/γ' containing clots and decreased α -chain crosslinking in γA/γ' clots, indicating that other factors likely play a role in the decrease of fibrinolysis rates by γ' fibrinogen. Our current data provide clear evidence for a role of γ' fibrinogen in the regulation of fibrinolysis rates also in plasma obtained from a large number of subjects with varying γ' fibrinogen levels.
As γ' fibrinogen level increases in individuals, CLT also increases and γ' fibrinogen has a larger effect on CLT than total fibrinogen. The results furthermore suggest that this association between γ' fibrinogen and CLT is not only the result of a denser clot network formed in the presence of higher γ' fibrinogen concentration as total fibrinogen had a larger impact on maximum absorbance than γ' fibrinogen and maximum absorbance did not correlate with CLT (data not shown). The mechanism by which γ' fibrinogen influences fibrinolysis rates should be further investigated using experimental models of clot formation and fibrinolysis.
In general, the association of γ' fibrinogen with CVD risk factors followed the same trend as that of fibrinogen. Increased levels were observed in women compared to men, subjects with increased BMI, increased waist circumference, elevated CRP and HbA1c categories and in individuals with metabolic syndrome as well as in individuals with low HDL-cholesterol. The association between γ' fibrinogen and these CVD risk factors remained significant after adjustment for total fibrinogen, and is accompanied also by an increase in the γ'/total fibrinogen ratio, suggesting that these associations are not merely reflecting the association of the CVD risk factors with total fibrinogen, but that they are likely independent relationships. These results are in agreement with the study of Lovely et al 32 who also found significant 1 3 associations between γ' fibrinogen and BMI, (decreased) HDL-cholesterol, diabetes, blood glucose and gender in Caucasians. In two other studies, γ' fibrinogen did, however not differ between genders 7;33 and while we and others 7;33 found no association between γ' fibrinogen and age, a positive association was found by another group. 32 In this study population, total fibrinogen increased over 10 year age categories and in individuals with increased total cholesterol (>5.2mmol/L), while no increase was observed for the γ' fibrinogen, resulting in a decreased γ'/total fibrinogen ratio.
In hyperhomocysteinaemic individuals on the other hand, decreased γ' fibrinogen was observed with no change in total fibrinogen consequently also decreasing the γ'/total fibrinogen ratio.
Multiple regression analysis indicated that fibrinogen concentration explained the largest percentage of the variation in γ' fibrinogen and that the CVD risk factors alone, excluding total fibrinogen, explained 20% and 3% of the variances of γ' fibrinogen and γ'/total fibrinogen ratio respectively, suggesting that the γ'/total fibrinogen ratio in apparently healthy black Africans, is not strongly affected by CVD risk factors other than γ' fibrinogen and total fibrinogen. The γ'/total fibrinogen ratio was, however, found to be different between several CVD patient groups and controls of Caucasian descent. 5;9;34 Of the other CVD risk factors, CRP were found to be the biggest determinant of both γ' fibrinogen and γ'/total fibrinogen ratio. These results are in agreement with a case-control study by Cheung et al 34 who found a significant association between CRP and γ'/total fibrinogen ratio in the acute phase of ischaemic stroke. These authors hypothesised that mRNA processing of γ'
fibrinogen may be altered during the acute phase reaction.
In conclusion, γ' fibrinogen levels increase as total fibrinogen increases, although to a lesser extent resulting in a decrease in γ'/total fibrinogen ratio at high fibrinogen concentrations in this apparently healthy black African population. Increases in both γ' fibrinogen and total fibrinogen were associated with increased maximum absorbance, in agreement with the formation of clots composed of increased fibrin material. However, the γ'/total fibrinogen ratio was associated with decreased maximum absorbance, in agreement with clots made of thinner fibrin fibres.
4
Increased γ' fibrinogen levels was associated with prolonged clot lysis. Traditional CVD risk factors (excluding fibrinogen) explained 20% and 3% respectively of the variance in γ' fibrinogen and γ'/total fibrinogen ratio, with CRP making the largest contribution. These data show that physiological levels of γ' fibrinogen influence fibrin clot structure in plasma and that factors other than fibrinogen, likely involved in the inflammatory response, regulate plasma γ' fibrinogen concentration. Our findings support future studies of the role of γ' fibrinogen in thrombosis.
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